Funds And Strategies
  • Business
  • Stocks
  • World News
  • Investing
  • Business
  • Stocks
  • World News
  • Investing

Funds And Strategies

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
Things are getting better at Boeing under CEO Ortberg, but can he keep it going?

Related Posts

Josef Schachter: Oil to US$80 by Q4? Plus...

May 24, 2025

Falco Announces Extension of Its Senior Debts

October 31, 2025

15 Canadian Crypto ETFs in 2025

August 12, 2025

Ian Rodger Appointed Managing Director

July 1, 2025

Chairman Joins Prime Minister’s India Trade Visit

October 11, 2025

RHI: Acqn of royalty over Sandstone Gold Project...

April 28, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (257)
    • Investing (1,578)
    • Stocks (206)
    • World News (648)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 fundsandstrategies.com | All Rights Reserved